Intraoperative coronary thrombosis: can aprotinin be incriminated?

[1]  T. Treasure,et al.  Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom. , 1993, The Annals of thoracic surgery.

[2]  S. Westaby.  Aprotinin in perspective. , 1993, The Annals of thoracic surgery.

[3]  R. Sapsford,et al.  Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency. , 1993, The Journal of thoracic and cardiovascular surgery.

[4]  R. Mohr,et al.  Platelet protection by low-dose aprotinin in cardiopulmonary bypass: electron microscopic study. , 1993, The Annals of thoracic surgery.

[5]  F. Loop,et al.  Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. , 1992, The Annals of thoracic surgery.

[6]  J. Pearson,et al.  Aprotinin inhibits platelet adhesion to endothelial cells , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[7]  J. M. Lipton,et al.  DOES APROTININ INHIBIT CARDIOPULMONARY BYPASSINDUCED INFLAMMATION , 1992 .

[8]  D. Dobnik,et al.  PREVALENCE OF PULMONARY ARTERY CATHETER ASSOCIATED THROMBUS DETECTED WITH TRANSESOPHAGEAL ECHOCARDIOGRAPHY , 1992 .

[9]  A. Griesmacher,et al.  Aprotinin decreases release of 6-keto-prostaglandin F1 alpha and increases release of thromboxane B2 in cultured human umbilical vein endothelial cells. , 1992, The Journal of thoracic and cardiovascular surgery.

[10]  W. Dietrich,et al.  High-dose aprotinin in cardiac surgery: three years' experience in 1,784 patients. , 1992, Journal of cardiothoracic and vascular anesthesia.

[11]  S. Westaby,et al.  Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. , 1992, The Annals of thoracic surgery.

[12]  D. Bouchier-Hayes,et al.  Aprotinin: the ideal anti-coagulant? , 1992, European journal of vascular surgery.

[13]  R. Mohr,et al.  Original articlePlatelet protection by aprotinin in cardiopulmonary bypass: Electron microscopic study , 1992 .

[14]  D. Royston.  High-dose aprotinin therapy: a review of the first five years' experience. , 1992, Journal of cardiothoracic and vascular anesthesia.

[15]  D. M. Morgan,et al.  Aprotinin Does Not Inhibit the Release of PGI2 or vWF from Cultured Human Endothelial Cells , 1992, Thrombosis and Haemostasis.

[16]  J. Soria,et al.  Hemostasis in Patients Undergoing Extracorporeal Circulation: The Effect of Aprotinin (Trasylol) , 1991, Thrombosis and Haemostasis.

[17]  J. E. Doran,et al.  Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. , 1991, The Journal of thoracic and cardiovascular surgery.

[18]  W. van Oeveren,et al.  The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass. , 1991, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[19]  H. Nagaoka,et al.  Effects of aprotinin on prostaglandin metabolism and platelet function in open heart surgery. , 1991, The Journal of cardiovascular surgery.

[20]  M. Jochum,et al.  Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. , 1990, Anesthesiology.

[21]  J. Youngberg.  Aprotinin and thrombus formation on pulmonary artery catheters: a piece of the coagulation puzzle. , 1990, Journal of cardiothoracic anesthesia.

[22]  D. Royston.  Aprotinin in open-heart surgery: background and results in patients having aortocoronary bypass grafts , 1990 .

[23]  H. Prydz,et al.  Synthesis of thromboplastin (tissue factor) by endothelial cells. , 1988, Haemostasis.

[24]  B. Spiess,et al.  Effects of Progressive Blood Loss on Coagulation as Measured by Thrombelastography , 1987, Anesthesia and analgesia.

[25]  V. Fuster,et al.  The pathogenesis and prevention of aortocoronary vein bypass graft occlusion and restenosis after arterial angioplasty: role of vascular injury and platelet thrombus deposition. , 1986, Journal of the American College of Cardiology.

[26]  T. Gelehrter,et al.  Dexamethasone induction of an inhibitor of plasminogen activator in HTC hepatoma cells. , 1984, The Journal of biological chemistry.

[27]  R. Ketterl,et al.  The effect of aprotinin on platelet function, blood coagulation and blood lactate level in total hip replacement - a double blind clinical trial. , 1984, Advances in experimental medicine and biology.

[28]  K. Oka,et al.  A histological study on microthrombi in autopsy cases of DIC. , 1983, Bibliotheca haematologica.

[29]  Herschlein Hj,et al.  [Difficulty in swallowing, painful swallowing and heartburn. Report of a round-table discussion]. , 1963 .